Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Conlon

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational studyTimothy M Walker, Maeve K Lalor, Agnieszka Broda, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Elife|August 22, 2020
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
Nature Communications|March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2021
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare WorkersSheila F Lumley, Jia Wei, Denise O'Donnell, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational studyTimothy M Walker, Maeve K Lalor, Agnieszka Broda, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2021
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination StatusSheila F Lumley, Gillian Rodger, Bede Constantinides, et al.
The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.
Elife|August 22, 2020
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational studyDavid W Eyre, Sheila F Lumley, Denise O'Donnell, et al.
Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.
Nature Communications|March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Pageof 3